AbVitro
Latest round
- Series A
Last raised
- Jun 2013
Total raised
- $7.4M
Investors
- 1
About AbVitro
Founded in 2010 and based in Massachusetts, US, AbVitro, Inc. develops an antibody discovery platform for the treatment of autoimmune diseases and cancer. AbVitro’s technology allows for the identification of fully human, natively paired T-cell receptors (TCRs) and chimeric antigen receptor (CAR) T-binders directly from cancer patients. In June 2013, AbVitro, Inc.
Who invested in AbVitro
1 investor across 2 rounds
See all investors in AbVitro
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AbVitro
Who invested in AbVitro?
AbVitro has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AbVitro raised?
AbVitro has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AbVitro last raise money?
AbVitro's most recent round on record is a Series A, in Jun 2013.
What does AbVitro do?
Founded in 2010 and based in Massachusetts, US, AbVitro, Inc.
Where is AbVitro headquartered?
AbVitro is headquartered in Boston, US.
Which VCs invest in companies like AbVitro?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AbVitro's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AbVitro? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.